These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19881961)

  • 1. Challenge and hope in radiotherapy of hepatocellular carcinoma.
    Seong J
    Yonsei Med J; 2009 Oct; 50(5):601-12. PubMed ID: 19881961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapeutic strategies in the management of hepatocellular carcinoma.
    Lee IJ; Seong J
    Oncology; 2011; 81 Suppl 1():123-33. PubMed ID: 22212946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.
    Walton M; Wade R; Claxton L; Sharif-Hurst S; Harden M; Patel J; Rowe I; Hodgson R; Eastwood A
    Health Technol Assess; 2020 Sep; 24(48):1-264. PubMed ID: 33001024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
    Wehrenberg-Klee E; Gandhi RT; Ganguli S
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview: Where does radiation therapy fit in the spectrum of liver cancer local-regional therapies?
    Dawson LA
    Semin Radiat Oncol; 2011 Oct; 21(4):241-6. PubMed ID: 21939852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.
    Chia-Hsien Cheng J; Chuang VP; Cheng SH; Lin YM; Cheng TI; Yang PS; Jian JJ; You DL; Horng CF; Huang AT
    Int J Cancer; 2001 Aug; 96(4):243-52. PubMed ID: 11474499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformal radiotherapy for hepatocellular carcinoma.
    Tse RV; Guha C; Dawson LA
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):113-23. PubMed ID: 18308583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitizers in hepatocellular carcinoma.
    Lee IJ; Seong J
    Semin Radiat Oncol; 2011 Oct; 21(4):303-11. PubMed ID: 21939860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
    Wang EA; Stein JP; Bellavia RJ; Broadwell SR
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma.
    Byun HK; Kim HJ; Im YR; Kim DY; Han KH; Seong J
    Radiother Oncol; 2019 Apr; 133():1-8. PubMed ID: 30935563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
    Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
    Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of radiotherapy and chemoradiation in the management of primary liver tumours.
    Aitken KL; Hawkins MA
    Clin Oncol (R Coll Radiol); 2014 Sep; 26(9):569-80. PubMed ID: 24951335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study.
    Wada Y; Takami Y; Matsushima H; Tateishi M; Ryu T; Yoshitomi M; Matsumura T; Saitsu H
    Intern Med; 2018 May; 57(10):1345-1353. PubMed ID: 29279513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study.
    Zhao JD; Liu J; Ren ZG; Gu K; Zhou ZH; Li WT; Chen Z; Xu ZY; Liu LM; Jiang GL
    Radiat Oncol; 2010 Feb; 5():12. PubMed ID: 20149262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy for hepatocellular carcinoma: from palliation to cure.
    Hawkins MA; Dawson LA
    Cancer; 2006 Apr; 106(8):1653-63. PubMed ID: 16541431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External beam radiotherapy for unresectable hepatocellular carcinoma.
    Abdel-Rahman O; Elsayed Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011314. PubMed ID: 28267205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
    Cheng JC; Chuang VP; Cheng SH; Huang AT; Lin YM; Cheng TI; Yang PS; You DL; Jian JJ; Tsai SY; Sung JL; Horng CF
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):435-42. PubMed ID: 10802371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiosensitivity of hepatocellular carcinoma].
    Hennequin C; Quero L; Rivera S
    Cancer Radiother; 2011 Feb; 15(1):39-42. PubMed ID: 21237689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
    Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
    Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma.
    Choi C; Koom WS; Kim TH; Yoon SM; Kim JH; Lee HS; Nam TK; Seong J
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1051-60. PubMed ID: 25303890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.